JamesConstantinePadussisMD
General Surgery • Omaha, NEHepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast), Minimally Invasive Surgery
Clinical Associate in the Department of Surgery, Duke University School of Medicine
Dr. Padussis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
987400 Nebraska Medical Ctr
Omaha, NE 68198Phone+1 402-552-2000Fax+1 402-552-2512
Summary
- Dr. James Padussis is a surgical oncologist in Omaha, NE and is affiliated with Nebraska Medicine - Nebraska Medical Center. He received his medical degree from Boston University School of Medicine and has been in practice 12 years. He specializes in GI and HPB surgical oncology.
Education & Training
UPMC Medical EducationFellowship, Complex General Surgical Oncology, 2013 - 2015
Duke University HospitalFellowship, Advanced GI Minimally Invasive Surgery, 2012 - 2013- Duke University HospitalResidency, Surgery, 2005 - 2012
Boston University School of MedicineClass of 2005
Certifications & Licensure
NE State Medical License 2015 - 2026
NC State Medical License 2005 - 2015
PA State Medical License 2013 - 2015
American Board of Surgery Surgery- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- Malignant tumors in tuberous sclerosis complex: a case report and review of the literature.Cassie Liu, Subodh M Lele, Martin H Goodenberger, Gwendolyn M Reiser, Andrew J Christiansen
BMC Medical Genomics. 2024-05-27 - 1 citationsGeographic variation in attitudes regarding management of locally advanced pancreatic cancer.Logan R McNeil, Alex B Blair, Robert W Krell, Chunmeng Zhang, Aslam Ejaz
Surgery Open Science. 2022-10-01 - 2 citationsSplenic and PB immune recovery in neoadjuvant treated gastrointestinal cancer patients.Kathryn E Cole, Quan P Ly, Michael A Hollingsworth, Jesse L Cox, Kurt W Fisher
International Immunopharmacology. 2022-05-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
